The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo - PubMed (original) (raw)

The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo

P V Liu. J Infect Dis. 1966 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa.
  Carney SA, Jones RJ. Carney SA, et al. Br J Exp Pathol. 1968 Oct;49(5):395-410. Br J Exp Pathol. 1968. PMID: 4973303 Free PMC article. No abstract available.
• The pathogenicity of rough strains of Pseudomonas aeruginosa for Galleria mellonella.
  Kropinski AM, Chadwick JS. Kropinski AM, et al. Can J Microbiol. 1975 Dec;21(12):2084-8. doi: 10.1139/m75-297. Can J Microbiol. 1975. PMID: 814978
• Production of enzymes and toxins by hospital strains of Pseudomonas aeruginosa in relation to serotype and phage-typing pattern.
  Wretlind B, Hedén L, Sjöberg L, Wadström T. Wretlind B, et al. J Med Microbiol. 1973 Feb;6(1):91-100. doi: 10.1099/00222615-6-1-91. J Med Microbiol. 1973. PMID: 4632256 No abstract available.
• Extracellular toxins of Pseudomonas aeruginosa.
  Liu PV. Liu PV. J Infect Dis. 1974 Nov;130 Suppl(0):S94-9. doi: 10.1093/infdis/130.supplement.s94. J Infect Dis. 1974. PMID: 4370620 Review. No abstract available.
• Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
  Homma JY. Homma JY. Jpn J Exp Med. 1980 Jun;50(3):149-65. Jpn J Exp Med. 1980. PMID: 6776324 Review. No abstract available.

Cited by

• Bacterial cell surface characterization by phage display coupled to high-throughput sequencing.
  Grun CN, Jain R, Schniederberend M, Shoemaker CB, Nelson B, Kazmierczak BI. Grun CN, et al. Nat Commun. 2024 Aug 29;15(1):7502. doi: 10.1038/s41467-024-51912-7. Nat Commun. 2024. PMID: 39209859 Free PMC article.
• Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa.
  Inoue K, Kinoshita M, Muranishi K, Ohara J, Sudo K, Kawaguchi K, Shimizu M, Naito Y, Moriyama K, Sawa T. Inoue K, et al. Vaccines (Basel). 2023 Jun 11;11(6):1088. doi: 10.3390/vaccines11061088. Vaccines (Basel). 2023. PMID: 37376477 Free PMC article.
• Structural Insights into Pseudomonas aeruginosa Exotoxin A-Elongation Factor 2 Interactions: A Molecular Dynamics Study.
  Gholami A, Minai-Tehrani D, Mahdizadeh SJ, Saenz-Mendez P, Eriksson LA. Gholami A, et al. J Chem Inf Model. 2023 Mar 13;63(5):1578-1591. doi: 10.1021/acs.jcim.3c00064. Epub 2023 Feb 20. J Chem Inf Model. 2023. PMID: 36802593 Free PMC article.
• Hfq-Assisted RsmA Regulation Is Central to Pseudomonas aeruginosa Biofilm Polysaccharide PEL Expression.
  Irie Y, La Mensa A, Murina V, Hauryliuk V, Tenson T, Shingler V. Irie Y, et al. Front Microbiol. 2020 Nov 17;11:482585. doi: 10.3389/fmicb.2020.482585. eCollection 2020. Front Microbiol. 2020. PMID: 33281751 Free PMC article.
• Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study.
  Wagener BM, Anjum N, Christiaans SC, Banks ME, Parker JC, Threet AT, Walker RR, Isbell KD, Moser SA, Stevens T, Alexeyev MF, Audia JP, Richter W, Hardy KS, Saleh LA, Morgan C, Pittet JF. Wagener BM, et al. Toxins (Basel). 2020 Jun 4;12(6):369. doi: 10.3390/toxins12060369. Toxins (Basel). 2020. PMID: 32512716 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations